Parkinson's Disease - Treatment Options, Symptoms, Causes & Diagnosis from MedifocusHealth

Parkinson's Disease > What Your Doctor is Reading About Parkinson's Disease > General Interest Articles

General Interest Articles

1. Freezing of gait affects quality of life of peoples with Parkinson's disease beyond its relationships with mobility and gait.

Author: Moore O; Peretz C; Giladi N;
Institution: Movement Disorders Unit, Department of Neurology, Tel-Aviv Sourasky Medical Center, Tel Aviv, Israel.
Journal: Mov Disord. 2007 Nov 15;22(15):2192-5.
Abstract URL: Click here to view abstract

2. Coffee and tea consumption and the risk of Parkinson's disease.

Author: Hu G; Bidel S; Jousilahti P; Antikainen R; Tuomilehto J;
Institution: Department of Health Promotion and Chronic Diseases Prevention, National Public Health Institute, Helsinki, Finland. hu.gang@ktl.fi
Journal: Mov Disord. 2007 Nov 15;22(15):2242-8.
Abstract URL: Click here to view abstract

3. Assessment of psychiatric complications in Parkinson's disease: The SCOPA-PC.

Author: Visser M; Verbaan D; van Rooden SM; Stiggelbout AM; Marinus J; van Hilten JJ;
Institution: Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands. m.visser@lumc.nl
Journal: Mov Disord. 2007 Nov 15;22(15):2221-8.
Abstract URL: Click here to view abstract

4. Six weeks of intensive treadmill training improves gait and quality of life in patients with Parkinson's disease: a pilot study.

Author: Herman T; Giladi N; Gruendlinger L; Hausdorff JM;
Institution: Movement Disorders Unit, Tel-Aviv Sourasky Medical Center, Department of Physical Therapy, Sackler School of Medicine, Tel-Aviv University, Israel.
Journal: Arch Phys Med Rehabil. 2007 Sep;88(9):1154-8.
Abstract URL: Click here to view abstract

5. Controlled study of decision-making and cognitive impairment in Parkinson's disease.

Author: Pagonabarraga J; Garcia-Sanchez C; Llebaria G; Pascual-Sedano B; Gironell A; Kulisevsky J;
Institution: Movement Disorders Unit, Neurology Department, Sant Pau Hospital, Autonomous University of Barcelona, Barcelona, Spain.
Journal: Mov Disord. 2007 May 29;.
Abstract URL: Click here to view abstract

6. Quality of life and related concepts in Parkinson's disease: A systematic review.

Author: Den Oudsten BL; Van Heck GL; De Vries J;
Institution: Medical Psychology, Department of Psychology and Health, Tilburg University, Tilburg, The Netherlands.
Journal: Mov Disord. 2007 May 21;.
Abstract URL: Click here to view abstract

7. Prospective study of coffee consumption and risk of Parkinson's disease.

Author: Saaksjarvi K; Knekt P; Rissanen H; Laaksonen MA; Reunanen A; Mannisto S;
Institution: 1National Public Health Institute, Helsinki, Finland.
Journal: Eur J Clin Nutr. 2007 May 16;.
Abstract URL: Click here to view abstract

8. Biopsychosocial predictors of depressive mood in people with Parkinson's disease.

Author: Moore KA; Seeney F;
Institution: The School of Psychology, Deakin University, Burwood, Australia.
Journal: Behav Med. 2007 Spring;33(1):29-38.
Abstract URL: Click here to view abstract

9. Bright light therapy in Parkinson's disease: A pilot study.

Author: Paus S; Schmitz-Hubsch T; Wullner U; Vogel A; Klockgether T; Abele M;
Institution: Department of Neurology, University of Bonn, Bonn, Germany.
Journal: Mov Disord. 2007 May 21;.
Abstract URL: Click here to view abstract

10. Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease.

Author: Wolozin B; Wang SW; Li NC; Lee A; Lee TA; Kazis LE;
Institution: Boston University School of Medicine, Boston, MA, USA. bwolozin@bu.edu
Journal: BMC Med. 2007 Jul 19;5:20.
Abstract URL: Click here to view abstract

11. Dementia and survival in Parkinson disease: a 12-year population study.

Author: Buter TC; van den Hout A; Matthews FE; Larsen JP; Brayne C; Aarsland D;
Institution: Section of Geriatric Psychiatry, Stavanger University Hospital, Arm Hansen v 20, N-4095 Stavanger, Norway.
Journal: Neurology. 2008 Mar 25;70(13):1017-22.
Abstract URL: Click here to view abstract

12. Parkinson disease and risk of mortality: a prospective comorbidity-matched cohort study.

Author: Driver JA; Kurth T; Buring JE; Gaziano JM; Logroscino G;
Institution: Harvard Medical School, Brigham and Women's Hospital, Division of Aging, 1620 Tremont St., Boston, MA 02120-1613, USA.
Journal: Neurology. 2008 Apr 15;70(16 Pt 2):1423-30.
Abstract URL: Click here to view abstract

13. The AMC Linear Disability Score in patients with newly diagnosed Parkinson disease.

Author: Weisscher N; Post B; de Haan RJ; Glas CA; Speelman JD; Vermeulen M;
Institution: Department of Neurology, H2-236 Academic Medical Center, 1105 AZ Amsterdam, The Netherlands. n.weisscher@amc.uva.nl
Journal: Neurology. 2007 Dec 4;69(23):2155-61.
Abstract URL: Click here to view abstract

14. Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson disease.

Author: Arabia G; Grossardt BR; Geda YE; Carlin JM; Bower JH; Ahlskog JE; Maraganore DM; Rocca WA;
Institution: Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA.
Journal: Arch Gen Psychiatry. 2007 Dec;64(12):1385-92.
Abstract URL: Click here to view abstract

15. Changes in quality of life in people with Parkinson's disease left untreated at diagnosis.

Author: Asimakopoulos P; Caslake R; Harris CE; Gordon JC; Taylor KS; Counsell C;
Institution: Crosshouse Hospital, Kilmarnock, UK.
Journal: J Neurol Neurosurg Psychiatry. 2008 Jun;79(6):716-8. Epub 2008 Jan 25.
Abstract URL: Click here to view abstract

16. Natural history and effectiveness of early detection of Parkinson's disease: results from two community-based programmes in Taiwan (KCIS no. 11).

Author: Liou HH; Wu CY; Chiu YH; Yen AM; Chen RC; Chen TF; Chen CC; Hwang YC; Wen YR; Chen TH;
Institution: Department of Neurology, National Taiwan University Hospital, Taipei, Taiwan.
Journal: J Eval Clin Pract. 2008 Apr;14(2):198-202. Epub 2008 Feb 18.
Abstract URL: Click here to view abstract

17. The frequency and nature of sleep disorders in a community-based population of patients with Parkinson's disease.

Author: Porter B; Macfarlane R; Walker R;
Institution: Parkinson's Disease Service, Northumbria Healthcare NHS Trust, Newcastle upon Tyne, UK. bobwillporter@aol.com
Journal: Eur J Neurol. 2008 Jan;15(1):50-4. Epub 2007 Nov 27.
Abstract URL: Click here to view abstract

18. Parkinson's disease dementia. An overlooked major illness.

Author: Libow LS;
Institution: Mount Sinai School of Medicine, New York, NY.
Journal: Geriatrics. 2007 May;62(5):11-2.

19. Effects of an extended version of the lee silverman voice treatment on voice and speech in Parkinson's disease.

Author: Spielman J; Ramig LO; Mahler L; Halpern A; Gavin WJ;
Institution: National Center for Voice and Speech, 1101 13th Street, Denver, CO 80204, USA. jspielman@dcpa.org
Journal: Am J Speech Lang Pathol. 2007 May;16(2):95-107.
Abstract URL: Click here to view abstract

20. Cardiac denervation in patients with Parkinson disease.

Author: Goldstein DS;
Institution: Clinical Neurocardiology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892-1620, USA. goldsteind@ninds.nih.gov
Journal: Cleve Clin J Med. 2007 Feb;74 Suppl 1:S91-4.
Abstract URL: Click here to view abstract

21. Features of probable multiple system atrophy patients identified among 4770 patients with parkinsonism enrolled in the multicentre registry of the German Competence Network on Parkinson's disease.

Author: Wullner U; Schmitz-Hubsch T; Abele M; Antony G; Bauer P; Eggert K;
Institution: Department of Neurology, UKB, Bonn, Germany.
Journal: J Neural Transm. 2007 May 18;.
Abstract URL: Click here to view abstract

22. The effect of age of onset of PD on risk of dementia.

Author: Aarsland D; Kvaloy JT; Andersen K; Larsen JP; Tang MX; Lolk A; Kragh-Sorensen P; Marder K;
Institution: Norwegian Centre for Movement Disorders, Stavanger University Hospital, Arm Hansen v 20, N-4005, Stavanger, Norway. daa@sir.no
Journal: J Neurol. 2007 Jan;254(1):38-45. Epub 2007 Feb 14.
Abstract URL: Click here to view abstract

23. Current advances in the treatment of Parkinson's disease with stem cells.

Author: Trzaska KA; Rameshwar P;
Institution: UMDNJ-New Jersey Medical School, Department of Medicine, Newark, NJ 07103, USA.
Journal: Curr Neurovasc Res. 2007 May;4(2):99-109.
Abstract URL: Click here to view abstract

24. New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: the role of dopamine agonist treatment and age at motor symptoms onset.

Author: Giladi N; Weitzman N; Schreiber S; Shabtai H; Peretz C;
Institution: Movement Disorders Unit and Parkinson Centre, Department of Neurology, Tel-Aviv Sourasky Medical Centre, Tel-Aviv, Israel and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Journal: J Psychopharmacol. 2007 Apr 19;.
Abstract URL: Click here to view abstract

25. Treatment of Levodopa-induced Dyskinesia.

Author: Rao J;
Institution: Jayaraman Rao, MD Parkinson's Disease and Movement Disorders Center, Department of Neurology, Ochsner Foundation Clinic, 1514 Jefferson Highway, New Orleans, LA 70121, USA. jrao@ochsner.org.
Journal: Curr Treat Options Neurol. 2007 May;9(3):205-209.
Abstract URL: Click here to view abstract

26. Nutritional therapies in Parkinson's disease.

Author: Evatt ML;
Institution: Marian L. Evatt, MD Department of Neurology, Movement Disorders Section, Emory University School of Medicine, 1841 Clifton Road NE, Atlanta, GA 30329, USA. marian.evatt@emoryhealthcare.org.
Journal: Curr Treat Options Neurol. 2007 May;9(3):198-204.
Abstract URL: Click here to view abstract

27. Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease.

Author: Hancock DB; Martin ER; Stajich JM; Jewett R; Stacy MA; Scott BL; Vance JM; Scott WK;
Institution: Center for Human Genetics and Department of Medicine, Duke University Medical Center, Durham, NC, USA.
Journal: Arch Neurol. 2007 Apr;64(4):576-80.
Abstract URL: Click here to view abstract

28. Prevalence and treatment strategies of dyskinesia in patients with Parkinson's disease.

Author: Muller T; Woitalla D; Russ H; Hock K; Haeger DA;
Institution: Department of Neurology, St Josef Hospital, Ruhr University, Bochum, Germany.
Journal: J Neural Transm. 2007 Apr 10;.
Abstract URL: Click here to view abstract

29. Estimated life expectancy of Parkinson's patients compared with the UK population.

Author: Ishihara LS; Cheesbrough A; Brayne C; Schrag A;
Institution: Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
Journal: J Neurol Neurosurg Psychiatry. 2007 Dec;78(12):1304-9. Epub 2007 Mar 30.
Abstract URL: Click here to view abstract

30. Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease.

Author: Voon V; Thomsen T; Miyasaki JM; de Souza M; Shafro A; Fox SH; Duff-Canning S; Lang AE; Zurowski M;
Institution: National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA. voonv@ninds.nih.gov
Journal: Arch Neurol. 2007 Feb;64(2):212-6.
Abstract URL: Click here to view abstract

31. The patient with Parkinson's disease: part I-treating the motor symptoms; part II-treating the nonmotor symptoms.

Author: Snyder CH; Adler CH;
Institution: Department of Neurology, Mayo Clinic Arizona, Scottsdale, Arizona 85259, USA. snyder.charlene@mayo.edu
Journal: J Am Acad Nurse Pract. 2007 Apr;19(4):179-97.
Abstract URL: Click here to view abstract

32. Management of impulse control disorders in Parkinson's disease.

Author: Galpern WR; Stacy M;
Institution: Mark Stacy, MD Duke University Medical Center, Division of Neurology, 932 Morreene Road, MS 3333, Durham, NC 27705, USA. stacy002@mc.duke.edu.
Journal: Curr Treat Options Neurol. 2007 May;9(3):189-97.
Abstract URL: Click here to view abstract

33. Levodopa response in long-term bilateral subthalamic stimulation for Parkinson's disease.

Author: Piboolnurak P; Lang AE; Lozano AM; Miyasaki JM; Saint-Cyr JA; Poon YY; Hutchison WD; Dostrovsky JO; Moro E;
Institution: Movement Disorders Center, Division of Neurology, University of Toronto, Toronto Western Hospital, Toronto, Ontario, Canada.
Journal: Mov Disord. 2007 Apr 18;22(7):990-997.
Abstract URL: Click here to view abstract

34. Cognitive impairment in Parkinson's disease.

Author: Verbaan D; Marinus J; Visser M; van Rooden SM; Stiggelbout AM; Middelkoop HA; van Hilten JJ; Verbaan D; Marinus J; Visser M; van Rooden SM; Stiggelbout AM; Middelkoop HA; van Hilten JJ;
Institution: Department of Neurology, K5Q-92, Leiden University Medical Centre, PO Box 9600, NL- 2300 RC Leiden, The Netherlands. D.Verbaan@lumc.nl
Journal: J Neurol Neurosurg Psychiatry. 2007 Nov;78(11):1182-7. Epub 2007 Apr 18.
Abstract URL: Click here to view abstract

35. Non-steroidal anti-inflammatory drugs in Parkinson's disease.

Author: Esposito E; Di Matteo V; Benigno A; Pierucci M; Crescimanno G; Di Giovanni G;
Institution: Istituto di Ricerche Farmacologiche "Mario Negri", Consorzio "Mario Negri" Sud, Santa Maria Imbaro (Chieti), Italy.
Journal: Exp Neurol. 2007 Jun;205(2):295-312. Epub 2007 Feb 23.
Abstract URL: Click here to view abstract